Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Non-immune Related Hypothyroidism in Iodine Sufficient Area
Completed
- Conditions
- Hypothyroidism
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2017-06-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 6564
- Registration Number
- NCT03180892
Usual Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin on Coronary Atherosclerotic Plaque
Phase 4
Recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 280
- Registration Number
- NCT03169985
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effect of Intensive Language Therapy in Subacute Stroke Patients
Not Applicable
Completed
- Conditions
- StrokeRehabilitationLanguage
- Interventions
- Procedure: language rehabilitation therapy
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT03168373
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effect of Intensive Motor Rehabilitation in Subacute Stroke Patient
Not Applicable
Completed
- Conditions
- RehabilitationStrokeMotor Function
- Interventions
- Procedure: Intensive motor rehabilitation
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 196
- Registration Number
- NCT03168386
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer
Phase 2
Completed
- Conditions
- Stomach Neoplasms
- Interventions
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 66
- Registration Number
- NCT03170180
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effect of Intensive Cognitive Rehabilitation in Subacute Stroke Patient
Not Applicable
Completed
- Conditions
- RehabilitationStrokeCognitive Function
- Interventions
- Procedure: Cognitive rehabilitation
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT03168360
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy
Phase 2
Withdrawn
- Conditions
- Solid Tumor
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2019-05-20
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT03166176
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy
Phase 2
Withdrawn
- Conditions
- Solid Tumor
- Interventions
- Drug: Vistusertib(AZD2014)
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2019-05-20
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT03166904
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Serum BDNF Role as a Biomarker for Stroke Rehabilitation
Completed
- Conditions
- BiomarkerBDNFStrokeRehabilitation
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT03164798
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib
- First Posted Date
- 2017-05-23
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT03163992
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath